- Our Story
- In Memory
Jason Eriksen, Ph.D.
Assistant Professor of Pharmacology, Department of Pharmacological and Pharmaceutical Sciences, University of Houston College of Pharmacy
Dr. Eriksen received his graduate school training at Loyola University Chicago, working on the development of an agent to treat Fetal Alcohol Syndrome. He received his postdoctoral training at the Mayo Clinic, studying Alzheimer’s disease and associated neurodegenerative disorders. His laboratory uses a variety of approaches, ranging from simple biochemical assays to high-content screening, in order to better understand the specific molecular and biochemical pathways that are involved in these Alzheimer’s disease and associated disorders.
Project Description Researchers Funding Peek and Treat Approach to Diagnosis, Treatment and Monitoring of AD
The objective of this project is to develop a nanotechnology platform that can simultaneously be used to diagnose and treat Alzheimer's. The work will explore how to develop multifunctional nanocarriers that contain both an imaging agent and a therpeutic agent and also will improve the binding capabilities of the nanocarrier allowing regulation of the release of therapeutic molecules to amyloid lesions.Ananth Annapragada, Ph.DJason Eriksen, Ph.D.